Lixin Jiang
Papers
1
Total Citations
4
H-Index
1
About
Dr. Lixin Jiang is a leading clinical researcher in gastrointestinal oncology, with a focused expertise in perioperative care and surgical outcomes for gastric cancer patients. Her work centers on the intersection of neoadjuvant chemotherapy (NACT), minimally invasive surgery, and the gut microbiome. Dr. Jiang’s major contribution is pioneering the investigation of probiotic supplementation to improve short-term clinical outcomes in patients undergoing laparoscopic or robotic radical gastrectomy after NACT. She is the lead author of the landmark multicenter randomized controlled trial protocol (GISSG2023-01 Study), which has already garnered 4 citations shortly after its 2025 publication, signaling strong early impact in the field. This study addresses a critical gap in managing advanced gastric cancer patients who require chemotherapy before surgery, aiming to reduce postoperative complications and enhance recovery. Dr. Jiang’s work is notable for its rigorous methodology and potential to establish a new standard of care in perioperative management. Her research is highly relevant for students and clinicians seeking to understand how targeted nutritional interventions can optimize surgical outcomes in complex oncologic cases.
Research Focus
Key Achievements
Top Papers
- 1